VistaGen Therapeutics Inc. (VTGN) Fell -9.66% or -0.14 To Price $1.31 On Thursday


VistaGen Therapeutics Inc. (VTGN) fell -9.66% or -0.14 to $1.31. It is close to 152796 shares traded, which is 85.68% compare to the average total volume 178332. The market cap of VTGN is $40.68 million. The year to date change is 15.35%. The 52 week price range is from $0.81 to $2.44. Price of VTGN have changed -11.04% during last week. It have changed -17.61% over last month, 8.21% over last 3 months, -0.68% over last 6 months and 30.63% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VTGN is 1.88. It is 43.51% above current price. The 200-day Moving Averages for VTGN is 1.42. It is 8.40% above current price. The 52-week High is 2.44. It is 86.26% from the current price. The 52-week Low is 0.81. It is -38.17% from current price.

There are some statistics of VTGN. It is has market cap $40.68 million. The share outstanding is 31.06 million. The average volume is 178332. It has 13.03M cash and 56300 in debt. The percent of top 15 Institution holding is 11.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VTGN is -1733.30%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VTGN is -347.91%.


Tags:

Share this post